Medical Devices: October 2016

Wednesday 26 October 2016

Cosmetic Dentistry Market: High cost of dental imaging systems could restrain the growth

Cosmetic dentistry refers to any work related to dental that changes and improves the look of a person's gums and/or bite, teeth. It primarily focuses on enhancement dental aesthetics in position, color, alignment, shape, size and overall smile appearance. Growing focus on dental aesthetics, increasing consumer awareness, growing dental tourism in emerging markets and increasing disposable incomes of middle-class population in developing nations are the major factors driving the growth of the cosmetic dentistry market. With increase in R&D investments, growing effort on technological innovations and various new products such as dental equipment and implant are being launched in cosmetic dentistry market, which are anticipated to further drive market growth. However, the high cost of dental imaging systems and lack of reimbursements for cosmetic dental procedures could restrain the growth of this market during the forecast period.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14693

Improvement of minimally invasive cosmetic dental procedures has permitted a lot of patients to undergo treatments that they did not prefer earlier. Technological advances have also allowed the utilization of novel techniques, and they are being used widely. Improved stress on new products being launched by the key players is another factor that has allowed the industry to prosper further. An increasing need for more esthetic appeal in the field of dentistry is being observed globally. This has generated the development of a wide range of techniques and procedures that cater to specific needs of the patients. Rising demand for dental implants and orthodontic appliances in the developing markets has caused a growth emission in dental tourism.

The major restraints that are delaying the growth of the cosmetic dentistry market are high cost of dental imaging and lack of reimbursement options. Cosmetic procedures are used to improve esthetics, hence, do not qualify as vital procedures. Thus, government agencies and insurance companies do not offer favorable reimbursement options to individuals opting for these dental procedures. Dental imaging requires costly instruments and equipment, which limits access to all due to financial constraints.

The global cosmetic dentistry market is segmented by product and region. On the basis of product, the market is segmented into dental systems & equipment, dental implants, dental bridges, dental veneers, dental crowns, orthodontic braces, inlays & onlays, and bonding agents. The dental systems and equipment market is further sub-segmented into instrument delivery systems, dental chairs, handpieces, light cure equipment, CAD/CAM systems, scaling units, dental lasers, and dental radiology equipment. The dental radiology equipment segment is categorized into extra-oral radiology equipment, intra-oral radiology equipment, and cone beam computed tomography (CBCT) scanners. The dental implants market covers titanium implants and zirconium implants. The dental bridges market is sub-segmented into traditional bridges, cantilever bridges, and Maryland bridges. The orthodontic braces market is sub-segmented into fixed braces and removable braces. Dental systems and equipment market accounted for the largest share of the cosmetic dentistry market. This is majorly due to the wide applications of dental equipment and systems in different dental procedures. The rising use of CAD/CAM systems for milling different prosthetics such as crowns, veneers, bridges, and inlays and onlays for cosmetic dental procedure have also contributed to the high share of this market.

Geographically, the global cosmetic dentistry market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Europe commanded a large share of the cosmetic dentistry market; however, Asia-Pacific is anticipated to witness the maximum growth rate during the forecast period. Growth in the Asia-Pacific market is due to improvements in healthcare infrastructure, increasing dental tourism and rising disposable incomes in developing countries like India and China. As a result of huge population, the proportion of individuals undergoing cosmetic dental procedures is much higher in this region. The extensive range of dental procedures being presented in this region has allowed propagation of dental tourism, adding to the industry’s market share.

Major players in cosmetic dentistry include Danaher, DENTSPLY International, 3M, Institut Straumann AG, Zimmer Biomet Holding, Align Technology, Sirona Dental Systems, BIOLASE, Planmeca Oy, and A-dec.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Fitness Equipment Market grows increase in health awareness among the young and old age groups

Fitness Equipment Market: Overview

With advancements in technology, today’s society is becoming more dependent on technology for their day to day activities. As every development or innovation has its pros and cons, it can be said that technological advancement has restricted the regular physical activities. Technology has directly or indirectly affected the human health in the recent past. This has created a greater need in society to increase the physical activities, to balance the body weight and cardiovascular fitness.

Keeping oneself physically fit can be considered as one of the best precautions to eradicate or avoid the risks of certain diseases. Fitness training centers have observed a spontaneous growth, due to the number of health issues encountered in today’s world. The increase in the number of fitness centers across the globe has created a rise in demand for fitness equipment and this demand is expected to grow in the coming years. Treadmills, stationary bicycles, weightlifting machines are some of the most common fitness equipment preferred by consumers for cardiovascular fitness and muscle building.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10670

Fitness Equipment Market: Drivers and Restraints

The recent growth observed in fitness equipment market can be attributed to the increase in health awareness among the young and old age groups. Doctors and governments of different countries are continuously striving to promote the benefits of physical fitness, thus creating health awareness in the society. In recent past, there has been rising health issues of diabetes, heart-related ailments and cholesterol. Further, obesity in developed countries is a major concern, thus making them susceptible to different diseases. These factors are driving the market for cardiovascular fitness equipment in developed regions such as North America and Europe.

Scientific research on human body structure has catalyzed innovation and development of fitness equipment, thus improving the fitness activities and delivering better results. Intense competition is a major factor to increase the stress among the individuals in today’s world. To remove the excess stress, youths are inclined to different fitness clubs for fitness activities. Moreover, improved lifestyles with economic growth, have increased the spending on fitness activities, thus adding to the demand for fitness equipment. Corporates are collaborating with different fitness training centers to provide fitness facilities to their employees.

The growing population in the developing countries is another reason for the fast growth of fitness equipment market. The age demographics of developing countries such as India, China, where majority of population is comprised of youths, creates good opportunities for fitness equipment market. Types of training equipment include cardiovascular training equipment, strength training equipment and others. Further, the market is categorized on the basis of users, which include home/individual usage, gyms and fitness clubs and commercial usage (hotels/corporate offices).

Fitness Equipment Market: Competitive Landscape

The market for fitness equipment is highly competitive with the presence of several local and multinational manufacturers across regions. The key companies operating in fitness equipment market include Star Trac Health and Fitness Inc., Body-Solid Inc., Yowza fitness, Precor Incorporated, Paramount Fitness Corp., NordikTrack Inc., Cybex International Inc., Body by Jake Global LLC, Nautilus Inc., ICON Health & Fitness Inc., Fitness EM, Johnson HealthTech, Motus, Impulse Health, Technogym, Elliptigo Inc., Torque Fitness LLC and Burnswick Corp.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Tuesday 25 October 2016

BRICS In vitro Diagnostics Market: China is expected to have the major share

In Vitro Diagnostics Market: Overview

In vitro diagnostics (IVD) is a suite of diagnostic tests performed using analytical instruments and reagents, on samples such as blood, stools, urine, tissues, and other body fluids. These samples are derived from patients or healthy individuals, to detect diseases or infections. Some of the significant technologies incorporated in in vitro diagnostics are polymerase chain reaction (PCR), immunoassays, and sequencing technologies. In vitro diagnostics play significant role in risk assessment, and disease monitoring. Great advances have been achieved lately, particularly in the field of clinical immunology Recombinant allergens have been investigated in diagnosing asthma and food, pollen-induced and insect allergies, in in vitro testing.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12959

In Vitro Diagnostics Market: Segmentation

The market can be segmented across different categories such as product types, applications, end users and geography. Based on product types, the market is segmented into, instruments, data management systems and reagents & kits. Based on application, the market is further segmented into, diabetes, infectious diseases, oncology, cardiology, nephrology, HIV, and other applications. Laboratories, standalone clinics, hospitals and patients form the major end-users of the market.

The in vitro diagnostic market comprises several tests such as thyroid function tests, renal function tests, lipid profiling, liver function tests, basic metabolism tests, immunoassays, Enzyme Linked Immunosorbent Assay (ELISA), radio Immunoassay (RIA), florescent Immunoassay (FIA), hematology, full blood count (RBC, WBC, and platelets), bone marrow testing, blood coagulation tests, biopsy, microbiology, and other IVD techniques.

In Vitro Diagnostics Market: Regional Insight

On basis of geography, the market has been segmented into five countries – Brazil, Russia, India, China, and South Africa. The BRICS IVD market is expected to have a healthy growth rate owing to the booming healthcare industry, thus driving the in vitro diagnostics market. China is expected to have the major share and is likely to remain the largest regional segment of BRICS countries, followed by Brazil, Russia, India, and South Africa.

Rampant economic growth observed in BRICS countries and emerging markets enabling patient base to afford diagnostic services has resulted in steady increase in healthcare expenditure. This is likely to remain an important driver for the BRICS IVD market in coming years. Increased awareness of diseases and personalized medicines, and rising health conscious urban population, combined with growing incidences of infections and diseases, has led to rise in demand for in vitro diagnostics in BRICS countries. Large aging population and prevalence of chronic diseases, combined with government support for healthcare market will drive the in vitro diagnostics market in China.

Brazil Chamber of Laboratory Diagnostics (BCLD) study demonstrated that out of the total in vitro diagnostics market, laboratories comprised 88%, followed by blood banks at 11%, whereas Point of Care (POC) testing centers comprised only 1%. Increasing healthcare budgets along with rising number of private hospitals, and income levels backed by huge untapped population base offer interesting growth opportunities for IVD market in Brazil. However lack of proper reimbursement policies and a stringent regulatory framework may hamper the market growth. IVD market in South Africa has reached a stable phase with growth concentrated around infectious diseases diagnostics. However price sensitivity, lack of reimbursement policies and labor shortages continue to prove a hindrance to the growth of IVD market in South Africa.

In Vitro Diagnostics Market: Key Players

The in vitro diagnostics market is competitive in nature and hence possesses higher threat to new entrants. Some major players of in vitro diagnostics market comprises Roche diagnostics, Siemens Healthcare, Danaher, Abbott Laboratories, Inc., Johnson & Johnson, and Bio Rad laboratories, Inc.

Traveler’s Diarrhea Market: Enterotoxigenic Escherichia coli is the most common causative agent

Traveler’s Diarrhea Market: Overview

Traveler’s diarrhea refers to intestinal and stomach infection and occurs due to unsanitary conditions during handling of food. This disorder is characterized by frequent abdominal cramps resulting in loose stools and is usually caused by consumption of contaminated water or food. Travelling from one place to another where the sanitary conditions, social conditions, climate and other factors are different and hence presents high risk of developing traveler’s diarrhea.

This is one of the most common condition affecting travelers every year, for example according to data enumerated by Centers for Disease Control and Prevention (CDC), around 20% to 50% an estimated 10 million of the international traveler’s develop traveler’s diarrhea every year. This disorder occurs during the travel period or post return and also in some cases one can experience multiple episodes of diarrhea during one trip. Developing countries of Latin America, Middle East, Asia and Africa represent the areas for highest risk of contracting traveler’s diarrhea. Immunosuppressed individuals, young adults and individuals with inflammatory bowel disorders and diabetic patients constitute the highly susceptible patient population for contracting traveler’s diarrhea.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13433

Intensity of infection varies depending on the type of eating establishment. For instance, there is low risk of infection if the food is consumed in private homes and poses high risk of infection in the food from the street vendors. Nausea, vomiting, fever, frequent defecate and abdominal cramps are some of the common symptoms of traveler’s diarrhea. Most of the cases are benign and resolve quickly but sometimes sign and symptoms persist for several days and can be more severe in cases where it is caused by other organisms other than common bacteria. In these cases, prescription medicines are recommended for the treatment. Enterotoxigenic Escherichia coli is the most common causative agent of traveler’s diarrhea. Travelers can minimize the risk of developing traveler’s diarrhea by adopting several preventive measures such as use of bottled drinking water, avoiding consumption of raw or uncooked seafood and meat and raw fruits.

Consulting a doctor than self medication is preferred for the treatment of traveler’s diarrhea and especially relevant to pregnant women and children. There are several medications prescribed for the treatment of diarrhea. For example, Pepto-Bismol tablet shortens the duration of illness and decreases diarrhea. This drug is not advised to take for more than three weeks at a time as it results in certain side effects such as temporary blackening of stools and tongue, constipation, nausea and others. Also, the consumption of this is not recommended for the patients who have aspirin allergy, gout, renal insufficiency and who are already taking anticoagulants. Other treatment options are replacement of fluids and salts achieved by the intake of oral rehydration solutions such as oral rehydration salts (ORS).

Traveler’s Diarrhea Market: Segmentation

The market for traveler’s diarrhea can be analyzed by the various medications available for the treatment and the geographical landscape. Antimicrobial therapy is the most preferred one and fluoroquinolones are the most preferred. The geographical landscape elucidates the analysis of the market by four major geographies namely North America, Asia-Pacific, Europe and Rest of the World. In addition, factors such as side effects of the drugs, introduction of alternate therapies, and increased focus on preventive care would impact the market growth.

Furthermore, regulatory policies, marketing approvals for drugs and safety concerns would further influence the market growth. The major factors favoring the market growth are increasing cases of traveler’s diarrhea and growing tourism across the globe. On the other hand, factors such as side effects of the drugs and lack of accessibility to appropriate treatment might encumber the market growth.

Bayer AG, Johnson & Johnson, Merck & Co., Inc. and Novartis AG are some of the companies operating in this market.

Mobility Scooter Market: Comparative High Cost than Wheelchairs is likely to Hinder the Growth of the Market Segment

Mobility scooters are electronic transport vehicles used as a mobility aid, mostly occupied by single person. These mobility scooters are operated on battery and varies from 3 wheels to 5 wheels. Mobility scooters assist in the movement of a person from one place to another, especially long distance travelling. Gasoline-powered scooters are very rare in the market and are being rapidly replaced by electric or battery-powered scooters. Mobility scooters are available in two forms worldwide: front-wheel drive and rear-wheel drive. Front-wheel drive scooters are smaller and are primarily used indoors, whereas the rear-wheel drive scooters are used both outdoors and indoors. The rider weight capacity of a rear-wheel drive scooter is higher than the front-wheel drive scooter. Mobility scooters acts as an alternative to wheelchairs and is expected to have a significant growth rate during the forecast period from 2016-2024. The use of mobility scooters are supported with government funding in most of the regions across the globe. However, comparative high cost than wheelchairs is likely to hinder the growth of the market segment. Thus, the government interventions has made the use of mobility scooter cost effective through various schemes offered to the users. The mobility scooters offers comfort, ease of use and elegance, which instead is not offered by traditional wheelchairs, makes the mobility scooter market more potential.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14141

Moreover, rising geriatric population, increasing incidences of knee and spine disorders, rising accidental and innate deformities are the important factors leading to the growing demand for mobility scooters globally. In order to assist the research and development in mobility aids, various national and international organizations participate actively along with regional government. Various government initiatives such as Affordable Care Act in the U.S., offers subsidy on mobility scooters for patients. Thus, market has high potential to grow in terms of its population reach, which is actively supported by government and non-government bodies. In addition, availability of mobility scooters in different designs and features has increased the attention of users towards mobility scooters. However, lack of infrastructure in many parts of the world and high cost of the devices restricts the uptake to some extent. Moreover, the use of refurbished mobility scooters is another biggest challenge faced by the market.

The mobility scooter market can be segmented into by type of design, by number of wheels, by distribution channel and by geography. In the terms of design, the mobility scooter is classified into boot scooters, mid-sized scooters and on road scooters. By wheels, the mobility scooter is classified into 3 wheels, 4 wheels and 5 wheels mobility scooters. By geography, the U.S. and European regions mainly U.K., occupies significant share of the mobility scooter market. North America dominates the market, due to government policies and high demand for mobility scooters. Moreover, baby boomer effect, sophisticated reimbursement policies, high awareness about the device are the other key factors favoring the market in North America. Followed by North America, Europe accounted for the second largest share of the global mobility scooters market due to increasing awareness and rising disposable income. However, Asia Pacific is expected to grow at a higher growth rate owing to huge untapped population and increasing health care awareness among the patient population.

The major players having presence in the global mobility scooters market include Invacare, Afikim Electric Vehicles., Drive Medical Design and Manufacturing, Golden Technologies Inc., Pride Mobility Products, Hoveround Corp., Sunrise Medical, Van Os Medical, Electric Mobility, Amigo Mobility International Inc., Quingo, among others.

Friday 21 October 2016

Global Demand for Bioprosthetics Market

Bioprosthetics are the material obtained from human or other species for medical implantations. Bioprostheses has shown significant advances from past few years, as their basic characteristic, they become degraded until their complete elimination in the host body. Bioprosthesis will gradually degrade in the recipient will determine the formation of a neotissue in its place, which will completely replace the biomaterial in the long term. Ideally , the bioprosthetics are to achieve not only the repair of the damaged zone but also the regeneration of an adequately organized tissue that will promote angiogenesis and even recruit growth factors acquiring characteristics similar to those of healthy tissue.

The raising prevalence of cardiovascular disorders, such as coronary and peripheral artery diseases, rheumatoid heart disease, and equivalently the demand for prolong relief is expected to broaden the base for the bioprosthetics market. Since the bioprothetic products are made up of biological materials, rate of rejection of implants is comparatively less than that of synthetic implants. The increasing aging population indicated with a raising degenerative cardiac diseases is fueling the bioprosthetic market. Whereas major factors that negatively affect the growth of this market include need of multiple surgeries, threat of infections and incompatibility (tissue rejection), irreversible nature and threat of uneven skin tone and scars after surgeries.

The new emergence in technologies with the novel innovations has evolve the progress in the field hybrid tissue-engineered bioprostheses, in which non-biodegradable cultured tissue scaffolds are used. These hybrid tissue-engineered bioprostheses are with high resistance and durability and can be alternatives for the biodegradable tissue-engineered prosthetics. The new technology which provide a sense of touch to the bio-prosthetics limb is being develop, which would revolutionize this field and allow many patients with limited options for restoring function to have near normal life-experiences. These technological advancements are expected to potentially decrease the morbidity and mortality rate associated with heart valve disorders, abdominal wall diseases, orthopedic disorders and others, which are expected to increase the share of bioprosthetics market.

The global bioprosthetic market can be segmented based on origin, applications, and geography. Applications segment comprises cardiovascular, nephrological, orthopedics, neurological, urogenital, ophthalmic, and others. Bioprosthetic according to the origin are classified as xenogenic (animal origin), allogenic (human origin), and tissue source (dermis, pericardium, or intestinal submucosa). Geographically, the bioprosthetic market is segmented into North America, Europe, Asia Pacific, and Middle-east and Africa. Where North America is expected to be the largest regional market for bioprosthetic market due to an increase technological innovations raising cardiovascular and orthopedic procedures. North America is a potential market for advanced products manufactured through innovation and transforming bioprosthetic technology. Europe accounts at the second largest position in the bioprosthetic market globally. Followed by Europe, the emerging economies in Asia Pacific and Latin America hold immense potential for the bioprosthetic market. The factors like increasing population, rise in incidence of obesity, rising incidences of road accidents with the high unmet medical needs and developing healthcare infrastructure are major drivers for the bioprosthetics in the emerging market.

Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14729

Some key players of the bioprosthetics market include Life Cell Corporation, Edwards Lifesciences Corporation, LeMaitre Vascular, Inc., CryoLife, Inc., Labcor Laboratorios Ltd., Maquet Metinge Group, Organogenesis, Inc., Braile Biomedica, Inc., Medtronic Plc., Humacyte, Inc., Aortech International Plc, JenaValve Technology GmbH, Sorin Group, Ethicon, Inc., St. Jude Medical, Inc., and others.

These key players are focusing on implementing the strategies like geographical expansion, new product launch, and strategic acquisitions and collaborations, to make strong hold on existing market and to explore the potential emerging markets.

Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) is increasing significantly. The market has huge scope due to growing demand for blood transfusion across the world. For the purpose of transfusion, donor blood compatibility with recipient patient is highly important. Thus, before transfusion of blood, in order to check compatibility, blood samples are cross-matched with each other. Transfusion of blood is usually safe, however, allo-immunization can create a complications in recipient. The allo-immunization can be dreadful in patients’ suffering from diseases like sickle cell anemia. The molecular blood group typing is used to determine presence of antigens in the red blood cells through testing. In general, A, B, and D (Rh) antigens are tested as part of standard procedure, followed by determination of other antigens if required. Reverse grouping confirms ABO blood group typing by detecting expected isoagglutinins. The varying use of blood typing and grouping test in research activities and transfusion procedures has upsurge the molecular blood typing, grouping and infectious disease nucleic acid testing market. Thus, rising demand, increased government interventions has increased the market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT). However, restraining factors like administrative and logistical challenges, slow turnaround, high cost, requirement of high end equipment and inadequate information systems for handling the results. Owing to these facts, the market observes rise in the demand for molecular typing tests. The adoption of molecular testing in blood transfusion procedures has mitigated the challenges faced to significant extent.

On the basis of nature of tests, blood typing and grouping tests are classified into ABO, Antibody Screening/Indirect Antiglobulin, Antibody Panels, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Rh (D, Du), Crossmatching (Immediate Spin, Full Crossmatch), etc. The cross-matching test has significant market share, followed by Antigen Typing in the molecular blood typing, grouping and infectious disease nucleic acid testing market.

Molecular diagnostics is gaining its popularity in transfusion procedures. The molecular diagnostics including NAT testing of infectious diseases has increased the safety of blood products and ensure blood group typing in critical situations such as prenatal non-invasive RhD typing and/or post-transfusion of blood products. Nucleic acid testing (NAT) in conjugation with serological procedures offers infectious disease screening standard which is generally used by blood banks globally. The evidence of positive impact of NAT blood screening on public health was observed globally. This led the rising potential for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) market. On the basis of infectious disease screening tests, the market is classified as Cytomegalovirus, AIDS (HIV NAT, HIV-1/2), Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), Parvovirus B19 NAT, HTLV-I/II, West Nile Virus NAT, Syphilis, etc.

Based on applications, the molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) market is classified into hospitals, diagnostic labs, research labs, blood banks, etc. the majority of share of market is occupied by blood banks.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14738

Geographically, North America occupies the largest market share followed by other developed region like Europe. United States have been the major market across the world. High and advanced technology, research and development activities has boosted the North America market for molecular blood typing, grouping and infectious disease nucleic acid testing. Moreover, Asia Pacific has shown striking increase in its growth rate for the molecular blood typing, grouping and infectious disease nucleic acid testing market. Rising population, increase in disposable income are some key factors driving the Asia Pacific Market. Due to this factors, the Asian market is observing high number of new entrants compared to those in developed regions.

The Major players reported in the market include Abbot Laboratories, Becton Dickinson, Bio-Rad, Thermo Fisher Scientific Inc., Danaher Corporation, etc.

Neurofibromatosis Type I Market Outlook and Forecast up to 2024

Neurofibromatosis is caused due to a genetic mutation, resulting in the formation of tumors in various parts of a body, along nerve tissues, brain, and spinal cord. Among the three types of this disease, neurofibromatosis type I (NF1) is the most common. Often diagnosed in early adulthood or childhood, NF1 records to affect one behind each 2,000-2,500 people worldwide. Neurofibromatosis type I is characterized by severe skin pigmentation i.e. skin color changes, in addition to tumor formation. These tumors, though benign initially, may turn malignant in later stages; and thus make it critical to seek the appropriate treatment in early stages.

Symptoms of neurofibromatosis type I typically include multiple flat patches or café-au-lait spots, which enlarge and multiply as patients grow older. On the other side, those in late childhood may develop freckles in groin and/or underarms. Although symptoms of the disease are relatively mild, it may progress with complicating consequences, such as extreme pain, loss of vision, loss of hearing, problems related to heart and blood vessels, learning impairment, and ADHD.

As far as treatment for NF1 is concerned, surgery can deal with large-sized tumors that press on nerves along which they are formed. However, a complete range of treatment options, such as medication/drug therapy, targeted therapy, genetic counseling, stereotactic radiosurgery, and palliative care, is available to address differing patient needs.

NF1 occurrence is also accompanied by higher risk of acquiring other types of cancers, leukaemia and brain tumor to name a few. Moreover, there are nearly 50% chances of inheritance in neurofibromatosis type I cases, when one of the parent, siblings, or close relatives is already carrying it. These potential consequences make it necessary to have an effective set of treatments against NF1. The ultimate aim of treatment remains managing complications at the earliest, healthy growth of patients, and maximized survival. Neurofibromatosis type I treatment, management, and therapeutics are witnessing moderate demand globally.

NF1 treatment does not assure complete cure and involves constant medication throughout the therapeutic course, which plays a key role in raising the demand for the disease treatment. Multiple clinical trials required for treating this disease also positively influence the NF1 treatment market growth.

Neurofibromatosis Type I Market: Segmentation

Based on treatment, the neurofibromatosis market is primarily segmented into diagnostics, medication or drug therapy, surgery, focused radiation therapy, chemotherapy, genetic counseling, and palliative care. Surgeries can cure completely remove tumors but always have chances of nerve damage, whereas focused radiation therapy effectively reduces tumor size and minimizes the risk of acquiring paralysis. Drug therapy in combination with chemotherapy does not ascertain 100% effectivity and complete tumor removal. Researchers are taking efforts toward developing new drug lines for complete and effective cure of this disease, which holds positive growth prospects for the market.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14744

Neurofibromatosis Type I Market: Key Players

Key players competing in the neurofibromatosis type I market include various organizations and research institutes. GL Pharm Tech Corporation, Erasmus Medical Center, Assistance Publique – Hopitaux de Paris, Texas Neurofibromatosis Foundation, University of Alabama at Birmingham, and Indiana University are some of the top names in the key players list.

Since the occurrence of neurofibromatosis varies from region to region, the report represents extensive geographical analysis to conclude the level of prominence of NF1 in the seven key regions, including North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and Middle East and Africa.

Ventilator Accessories Market: Applications and Global Markets

Ventilators are critical life-support devices that provide respiratory therapy to millions of patients every single day. The ventilator accessories market unveils the characteristics of an increasingly mature market with innovative brands & unique product differentiation in order to secure competitive advantage. The ventilation accessories segment includes flow sensors, breathing sets, expiratory valves, endotracheal tubes, breathing circuits, humidifiers, interfaces, masks & lot more. The relatively inclusive range of end use sectors and specialist applications for innovative ventilator accessories represents a supportive factor in terms of the long term market growth. Large medical device manufacturers are majorly focused on launching novel products in order to accomplish development in the global ventilators market. Companies are also more attentive on collaboration by acquiring domestic and international players to expand their product portfolios and boost their distribution channels in emerging markets. High-tech advancement is another key factor for manufacturers to improve technologies and thus prevent respiratory illness and reduce the time spent on other ventilation procedures.

Drivers & Restraints

Rising elderly population, growing prevalence of respiratory disorders, and rising number of preterm births are predictable to fuel the growth of ventilators accessories market in the forecast period. Ventilator accessories market growth has been driven by increasing in sales of portable and mechanical ventilators. Furthermore there is also an increase in the relevance of hospitals, medical emergency services and rehabilitation centers can be expected to rise in the demand for ventilators. Industry experts design these accessories utilizing the high grade standard material with high-end technology. Manufacturers are mainly focused for the highest possible patient safety and ease of use. Growing per capita income, extensive R&D investments in the healthcare industry by top market players, rising demand for advanced front-line technologies, and expansion of private hospitals and rehab-centers in remote areas are the major factors driving growth of the ventilators accessories market globally. Also, lack of access to primary care in developing regions is comparatively driving sensitive demand for urgent respiratory care utilization. Patient safety and operator control safety is the prime concern which has been regulated by the few official authorities which has executed huge challenges for the medical device manufacturers. New materials may bring together biocompatibility and circuitry issues.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15299

Global Ventilators Market: Segmentation

The Global Ventilators Market market can be segmented as follows:

Global ventilator accessories market by Product Type

Flow sensors
Breathing sets
Expiratory valves
Endotracheal tubes
Breathing circuits
Humidifiers
Interfaces and masks
Others

Global Ventilators Market, by End User

Hospitals
Ambulatory Surgery Centres
Clinics
Emergency Medical Services
Long term care centres

Global Market: Regional Outlook

Geographically, the global ventilator accessories market is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific & the Middle East and Africa (MEA). North America (U.S) is the largest regional segment of the overall ventilator market, followed by Europe region. Currently Asia-Pacific region has also enhanced the growth rate during the forecast period. The rate of efficiency is mainly attributed to the geriatric population worldwide, rising incidences of cardio-vascular & respiratory diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry worldwide. These regions are expected to generate the fastest growth rates potentially.

Global Ventilators Market: Key Players

The key players in the Ventilators market are

Drägerwerk AG & Co. KGaA
GE Healthcare Ltd.
Siemens Healthcare
ResMed Inc.
Fisher & Paykel Healthcare Corp. Ltd.
Hamilton Medical AG
Invacare Corp.
CAS Medical Systems Inc.
Nihon Kohden Corp.
Nonin Medical Inc.
Criticare Systems Inc.
Spacelabs Healthcare Inc.
Nellcor Puritan Bennett LLC
ALARIS Medical Systems Inc.
Criticare Systems Inc.
Masimo Corp.
Welch Allyn Inc.

The global market for ventilator accessories market is further expected to witness significant growth over the report’s forecast period owing to the rapid and consistent technological innovation in these medical devices and the rising cases of chronic respiratory disorders among people worldwide.

Live Cell Imaging Market - Worldwide Market Shares, Strategies, and Forecasts 2016 to 2024

Live Cell Imaging Market: Overview

Live cell imaging is the use of time lapse microscopy to study the living cells. The scientists use it to get a better understanding of the biological functions with the help of cellular dynamics. The live cell imaging technique is becoming increasingly popular in the healthcare industry.

The market can be categorized by products, by technologies, by end users and by regions. By product types, the live cell imaging market can be segmented into instruments, consumables and softwares. The instruments segment can be further sub-divided into standalone systems, cell analyzers, microscopes and image capturing devices. By technologies, the market can be segmented into fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), fluorescence in situ hybridization (FISH), ratiometric imaging, total iternal reflection fluorescence microscopy (TRIF), and multiphoton excitation microscopy (MPE) among others. Furthermore, the market can be segmented by applications into pharmaceutical industry, contract research organization, government and academic organization and diagnostic laboratories.

Live Cell Imaging Market: Trends and Opportunities

The rising concern of cancer is one of the major factors behind the growth of increasing demand of this technology. Furthermore, the government is actively taking initiatives to fund cell based research. Moreover the live cell imaging has a wide area of application and it can used to understand dynamic processes and cellular structures. In addition, it can also be used to study cellular integrity, protein trafficking, enzyme activity, localization of molecules, exocytosis and endocytosis among others. Furthermore, the process can also be applied to monitor the molecules in live animals. Moreover, the pharmaceutical companies are increasingly using live cell imaging in research and development in order to develop new medicines. In addition, the live cell imaging is also used for high content screening.

However, the cost of implementing live cell imaging is very high is acting as a restraint for the market. Moreover, the technology requires highly skilled professional in order to study and understand the cell functions. The lack of availability of skilled professional is also expected to restrain the growth of live cell imaging market. However, with increasing investments in training and development programs this factor is expected to have low impact in the long run. In addition, the live cell imaging technique is gradually being applied by pharmaceutical companies to develop personalized medicine. This demand is expected to grow in future.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7688

Live Cell Imaging Market: Geographical and Competitive Dynamics

By geography, the market can be divided into North America, Europe, Asia Pacific and Rest of the world. North America and Europe are the early adapters of technology. Furthermore, government initiatives are being taken in this region for research and development using live cell imaging. U.S. is the largest market for live cell imaging in North America. However, Asia Pacific region is expected to witness robust growth due to presence of developing nations such as India and China.

The key players in the live cell imaging market are Sigma-Aldrich Corporation, Nikon Corporation, GE Healthcare, Carl Zeiss AG, Danaher Corporation, Olympus Corporation and Thermo Fisher Scientific, Inc., Molecular Devices, LLC, Becton, Dickinson and Company and Perkinelmer, Inc. among others.

Laser Capture Microdissection Market Offering High-growth Opportunities for Market Players

Laser Capture Microdissection Market: Overview

Laser capture microdissection (LCM) technology is a contamination free procedure for obtaining subpopulations of tissue cells under direct microscopic visualization. Furthermore, laser-capture microdissection technology isolates specific cells by dissecting unwanted cells. Laser capture microdissection technology harvests the cells of interest directly to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The laser capture microdissection technology by type can be segmented into software, instruments, consumables, and services. Furthermore, the market for laser capture microdissection by system can be segmented into infrared LCM, ultraviolet LCM and Immunofluorescence LCM. In addition, by end users the laser capture microdissection market can be segmented into biotechnology and pharmaceutical companies, hospitals and government research institutes among others. Moreover, by application the market can be segmented into research and development and diagnostics among others.

The laser capture microdissection market by geography has been segmented into Europe, Asia Pacific, North America and Rest of the World (RoW).

Laser Capture Microdissection Market: Trends and Opportunities

Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level. In addition, growing funding and expenditure on research and development activities of companies involved in this market is stimulating the growth of this market. High maintenance and manufacturing cost of accessories and equipment along with lack of expertise professionals in this field is some of the restraining factors which may hinder the growth of this market.

Research and development and diagnostics among others are major application areas of laser-capture microdissection technology. Furthermore, government research institutes and hospitals are major end users of this technology. Moreover, ultraviolet LCM and infrared LCM are leading the market globally. Increasing preference of laser-capture microdissection technology in forensic science and molecular biology under the research and development application segment is one of the major driving factors for the market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Laser Capture Microdissection Market: Geographical and Competitive Dynamics

With the increasing technological advancement and growing application of laser-capture microdissection (LCM) technology in pharmaceuticals, hospitals and research and development institutes are fueling the market globally. North America dominated the market for laser-capture microdissection in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Moreover, with the increasing expenditure on research and development activities of companies dealing in this market along with increasing awareness regarding the technological advancement is driving the market for laser-capture microdissection across Asia Pacific. China, Japan, India, contributes in the positive growth of this market across Asia Pacific. Growing application areas of this technology in the fields such as forensic science, diagnostics and molecular biology are having a positive impact on the growing market for laser-capture microdissection in Rest of the World (RoW).

Some of the key players operating in the laser capture microdissection market are Carl Zeiss AG (Germany), Molecular Machines & Industries (Germany), Ocimum Biosolutions LLC (U.S.), DeNova Sciences Pte. Ltd. (Singapore), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Indivumed GmbH (Germany), AvanSci Bio, L.L.C. (U.S.), Theranostics Health, Inc.(U.S.) and 3DHISTECH Ltd. (Hungary) among others.

Thursday 20 October 2016

Global Medical Waste Management Market to Reach US$20.1 bn by 2019, Rapid Expansion of Healthcare Industry to Drive Growth

The competitive landscape of the global medical waste management market comprises a large number of locally owned companies along with firms with a multinational reach. These companies compete intensely over prices of the products, reports Transparency Market Research (TMR) in a new study. A common trend in the global medical waste management market is the acquisitions of small companies by large companies in order to increase their consumer base across different regions. For instance, Stericycle, Inc. has acquired more than 350 companies across the globe in a bid to establish a presence in high-potential regions. In 2015, the valuation of the global medical waste management market was US$16.60 bn and is anticipated to reach US$20.13 bn by 2019, at a positive CAGR of 4.8% between 2013 and 2019.

Some of the key companies are Stericycle Inc., Republic Services Inc., Waste Management Inc., and Clean Harbors Inc. “The onsite treatment of regulated medical waste materials by bulk producers of waste such as hospitals and big pharmaceutical companies is regarded as one of the major challenges to the global medical waste management market,” says the author of the report. However, the low threat of new entrants due to high capital investment will keep the overall competition level medium clearing the way for larger companies to expand their business.

Government Regulations to Help in High Adoption of Medical Waste Management Systems

To ensure the safe handling and disposal of hazardous medical waste, governments of countries such as France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom have obligated proper disposal of medical waste in their respective countries. As a result, the healthcare sector is seeking help from companies offering waste management services. Therefore, these government legislations and regulations are encouraging the growth of the global medical waste management market.

During the recent times, non-incineration technologies have been largely deployed as an alternative method to incineration, which results in harmful gaseous emissions such as dioxins, carbon monoxide, furan, and sulfur dioxide. The increasing global pressure to cut down these emissions has encouraged the demand for non-incineration technologies, thereby propelling the growth of the global medical waste management market.

Another factor influencing the growth of the global medical waste management market is the rising geriatric population. The fact that aged people require more diagnostic tests, medications, and surgical procedures ultimately stimulates the need for medical waste management systems for this demographic. The increase in the number of off-site treatment alternatives will also result in an increased amount of medical waste generated, thus heightening the demand for medical waste management system. These factors are contributing to the robust growth of the global medical waste management market.

High Competitive Rivalry to Adversely Affect Overall Revenue Earnings

State licensing, vehicles for waste transfer, storage sites, and land filling sites required for safe and legal waste management systems demand high capital investment. This is likely to impede the growth of the global medical waste management market and pose a barrier for new entrants.

The global medical waste management market is highly fragmented with a large number of regional and local players. These small and local players provide waste management services at low prices, thereby affecting the prices set by large companies and giving rise to a price war among players. The price war is likely to act as a restraint that may reduce the overall revenue earnings of the global medical waste management market.

However, vendors are shifting their focus towards small quantity waste generators which offer relatively higher profit margins, thereby creating new growth opportunities for the global medical waste management market.

High Adoption Rate of Processing Amongst Vendors Owing to Extra Income Earned through it

In terms of waste generators, the market is segmented into large quantity generators (LQGs) and small quantity generators (SQGs). The LQGs will be the leading segment by revenue between 2015 and 2019. This segment was valued at US$11.34 bn in 2015 and is expected to reach US$12.94 bn by 2019. However, the SQGs segment will show the most rapid growth during the same period owing to the ever increasing patient population and restrictions over on-site disposal of hazardous or infectious waste.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2268

By activity type, the collection segment was the leading segment by revenue in 2015 and is anticipated to hold the dominant share in the coming years. However, the processing segment is estimated to show fast growth owing to the growing utilization of non-incineration technologies for waste management. Processing is adding another stream of income for the vendors operating in the medical waste management industry.

Based on geography, North America is expected to hold a dominant share of revenue from 2015 to 2019. The valuation of the North America segment was US$7.24 bn in 2015 and is estimated to rise to US$8.71 bn in 2019. The Asia Pacific region, however, will be the fastest growing segment during the same period influenced by factors such as the high economic growth in key countries, increasing awareness level and rising healthcare expenditures.

The information presented in this review is based on a Transparency Market Research report, titled, ‘Medical Waste Management Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.’

Rising Demand for Reducing Medical Costs Drive Global Medical Equipment Rental Market

Rising health care expenditure and increasing demand for novel medical equipment have led to a surge in the medical equipment manufacturing industry. However, product pricing is affected by the demand-supply gap or increased raw material costs. In either case, procuring new equipment is seen as an expensive proposition for several medical institutions, especially those with funding restraints. Renting/leasing medical equipment has emerged as a boon or an alternative to equipment purchasing to these medical institutions, benefitting the end-users or patients indirectly. Home care products have seen a similar pattern with a majority of products being quite expensive for acute care patients, as the duration of the product requirement is too small to avail any benefits in the long run. The rental market, therefore, has seen a surge in recent times, with preference of the personal/home care patients for smaller devices and of medical institutions for larger equipment. The multi-billion dollar medical equipment rental market is expected to rise by a little less than half by the end of the decade and would remain dynamic for the next few years.

The global medical equipment rental market has been segmented based on device category, end-users and geography. The device category has been further segmented into personal/home care equipment, electronic/digital equipment, surgical equipment, durable medical equipment, and storage and transport. The durable medical equipment segment accounted for the largest share of over 40% of the medical equipment rental market in terms of revenue in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020, expanding at a CAGR of over 5%. High cost and increased demand has led to the growth of the durable equipment rental segment. The trend is likely to continue due to the increasing geriatric population across the world.

Based on end-users, the medical equipment rental market has been segmented into personal/home care medical equipment rental and institutional medical equipment rental. The chronic and geriatric patients sub-segment accounted for the largest share of over 50.0% of the personal/home care medical equipment rental segment in 2013. It is expected to lead the market during the forecast period. The chronic and geriatric patients segment is expected to rise with the increase in the number of patients suffering from chronic illnesses and the increasing geriatric population.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2543

Europe was the largest market for rental medical equipment in terms of revenue in 2013, followed by North America. Medical institutions in Europe aim to reduce costs through renting/leasing of medical equipment. However, North America is expected to surpass Europe in terms of market share during the forecast period due to the high adoption rate and increasing preference for rental medical equipment. Asia Pacific is anticipated to be the fastest growing market during the forecast period. Rapidly growing population and increasing government initiatives in emerging countries such as China and India are some of the factors attributed to the high growth rate in the region. In addition, the presence of a large number of companies manufacturing cheaper equipment and increasing investments by health care medical institutions would ensure steady market penetration and growth in the near future.

The global medical equipment rental market is highly fragmented, with only a few large players dominating it. Apria Healthcare Group, Inc., Stryker Corporation, Hill-Rom Holdings, Inc. and Siemens Financial Services, Inc. exhibit the largest geographical reach with presence in multiple device categories and catering to varied end-user segments. Their presence in developed and emerging regions along with flexible offerings has made them attractive providers in the global market. Other companies include Centric Health Corporation, Hill-Rom Holdings, Inc., Nunn’s Home Medical Equipment, Port Huron Hospital Medical Equipment, US Med-Equip, Inc., Universal Hospital Services, Inc., Woodley Equipment Company Ltd., Walgreen Co., and Westside Medical Supply, Inc.

Lyme Disease Diagnostic Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2013 - 2019

Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it affects heart, joint and central nervous system and might become a cause for death.

The lyme disease diagnostic market is segmented on the basis of diagnostic tests, emerging diagnostic technologies and end users. Emerging technologies segment comprises of molecular diagnostics, monoclonal antibodies, immunoassays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, diagnostic imaging, gel microdroplets, chromatography and others. The endusers segment of the market includes hospitals, commercial/private labs, public health labs and physicians office. Various forms of laboratory testing for lyme disease are available and among them most widely used are serological test. Among the serological tests most commonly used are ELISA and Western Blot. Moreover, some laboratories offer tests that include urine antigen tests, lymphocytic transformation test, immunofluorescent staining and PCR tests. New lyme disease diagnostic tests are being developed that are particularly suited for diagnosis of chronic lyme infection using blood sample. These tests overcome the accuracy problems which were encountered in serology based tests.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1658

Globally North America accounts for the largest share of the market owing to the most common tick disease in the U.S. According to the Center for Disease Control and Prevention (CDC) in 2011, 24,364 people were diagnosed with lyme disease in the United States. The European and Asian markets are also expected to emerge in near future owing to increase in patients infected with lyme diseases.

Some of the key players engaged in manufacturing of diagnostic tests include Abbott Laboratories, Affymetrix, Inc., Bio-Rad, Roche Diagnostics among others.

Global Regulatory Affairs Outsourcing Market will exhibit a healthy 11.5% CAGR from 2015 to 2023

Life sciences companies can end-up spending nearly one-third of their regulatory resources for the maintenance of products that are already approved and are in the market. These maintenance activities, which provide almost no competitive advantage but are critical to maintain sales, may restrict a company from putting its best regulatory resources for core competencies and innovations.

Today’s evolving healthcare landscape already poses many challenges to life science companies in terms of restructuring, consolidation, globalization, and budget cuts. Add to this the vast product portfolios of today’s life science companies covering numerous verticals and we get an operational landscape that is ripe with unprecedented challenges for survival. To compete effectively in such a scenario, life science companies are presented with the dire necessity to put more focus on core competencies.

Browse Market Research Report of Regulatory Affairs Outsourcing Market: http://www.transparencymarketresearch.com/global-regulatory-affairs-outsourcing-market.html

Companies are thus considering outsourcing of a number of non-core but highly critical processes, such as regulatory maintenance, as a way to address the numerous challenges and benefit from a variable cost model for regulatory maintenance abilities via an agile workforce. Regulatory outsourcing allows companies to apply a multidisciplinary expertise to their regulatory affairs and operations, thereby leading to reduced costs, improved processes, and accelerated approvals.

Increasingly Stringent Regulatory Requirements Lead to Rising Adoption of Regulatory Outsourcing

The stringent regulatory framework ruling the manufacturing, testing, and distribution landscape of drugs and medical devices across the globe is impelling life science companies to outsource regulatory affairs as a cost-competent and much effective tool for satisfying the diverse requirements of different regions. Currently, more than 70% of the world’s major pharmaceutical companies are outsourcing their regulatory affairs. This represents a huge growth over the past decade as regulatory burdens have increased. Companies may have a variety of reasons for regulatory outsourcing, such as more product launches than can be handled by internal teams. With the help of a regulatory outsourcing partner, companies can benefit from additional expertise that can be brought in as the need arises.

A research report published by market research company Transparency Market Research states that the global market for regulatory outsourcing had a valuation of US$1.56 billion in 2013. Developing at a 14.6% CAGR between 2014 and 2020, the market is expected to rise to a valuation of US$4.49 billion by 2020. The services of regulatory writing and publishing held a nearly 40% of the global regulatory outsourcing market in 2013, adds the report.

View exclusive Global strategic Business Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3528

Life Science Companies Need On-the-Ground Expertise to Survive in Regional Territories

The growth and profits of life sciences companies depend on their business in the international market. With the rising globalization, a need for a broader level of on-the-ground, local expertise has risen before the life sciences industry. Lucrative regional markets such as Brazil, India, China, and Russia come with their own individual set of rules. Even in the European Union, there can be 28 different sets of regulations according to each of its member states.

For efficient operations in such varying sets of regulations, companies need to appreciate the difference in cultures and bureaucracies, which can be a huge challenge for growing life science companies. This presents the need for regulatory expertise on local, regional as well as national levels. Outsourcing regulatory affairs to a trusted partner having a global footprint can make the task easy and add to the competitive advantage of the company.